MicroRNA-505 suppresses gastric cancer cell proliferation and invasion by directly targeting Polo-like kinase-1
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 795-803
Abstract
Purpose: The expression of microRNA-505 (miR-505) has been investigated in various cancers; however, its effect and mechanism in relation to gastric cancer (GC) are yet to be determined. Thus, the current evaluation aimed to examine the expression and potential role of miR-505 in GC. Materials and methods: Quantitative real-time PCR was carried out to analyze miR-505 expression in GC cells and tissues. We observed that miR-505 is differentially expressed in GC cells following transfection of its mimics or inhibitors. Changes in cell invasion, cell proliferation, and epithelial–mesenchymal transition markers were measured. Results: These findings indicated that miR-505 expression is downregulated in both GC cell lines and GC tissues. In addition, knockdown miR-505 induced the invasion and proliferation of GC cells. Transfection of miR-505 mimics led to an elevation in N-cadherin expression but a decrease in E-cadherin expression. Furthermore, we have shown that miR-505 binds to the 3'-UTR region of Polo-like kinase-1. Conclusion: Our results indicated that miR-505 suppresses GC cell proliferation and invasion; it may be a valuable candidate gene for seeking therapy strategy for GC.Keywords
This publication has 25 references indexed in Scilit:
- Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markersExpert Reviews in Molecular Medicine, 2014
- Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysisEuropean Journal of Cancer, 2013
- Regulation of mRNA Translation and Stability by microRNAsAnnual Review of Biochemistry, 2010
- Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the NetherlandsEuropean Journal of Cancer, 2010
- Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid CarcinomaCancer Research, 2009
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor MetastasisDevelopmental Cell, 2008
- Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric CarcinomaOncology, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor gradesThe Prostate, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001